Olanzapine in treatment-resistant bipolar disorder

Journal of Affective Disorders

Volumn 49, Issue 2, 1998, Pages 119-122

  McElroy, Susan L ^a   Frye, Mark ^b   Denicoff, Kirk ^b   Altshuler, Lori ^c   Nolen, Willem ^d   Kupka, Ralph ^d   Suppes, Trisha ^e   Keck Jr , Paul E ^a   Leverich, Gabrielle S ^b   Kmetz, Geri F ^a   Post, Robert M ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Willem Arntz Huis   (Netherlands)

^e St Paul Prof Bldg #1 ^*  (United States)

Author keywords

Bipolar disorder; Olanzapine

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; LITHIUM; OLANZAPINE; TRANYLCYPROMINE; TRIFLUOPERAZINE; VALPROIC ACID;

APPETITE DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; DRUG TOLERABILITY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; SOMNOLENCE; TREMOR; WEIGHT GAIN; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; HUMANS; PIRENZEPINE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 18344409122     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(98)00002-0     Document Type: Article

References (10)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington DC.
2. Calabrese, J.R., Kimmel, S.E., Woyshville, M.J. et al., 1996. Clozapine for treatment-refractory mania. Am. J. Psychiatry 153, 759-764.
3. Frye, M.A, Ketter, T.A., Altshuler, L.L. et al. Clozapine in bipolar disorder: treatment Implications for other atypical antipsychotics. J. Affect. Disord., in press.
4. Guy, W. (Ed.), 1976. Clinical Global Impressions. In: ECDEU Assessment Manual Psychopharmacology, revised. National Institute of Mental Health, Rockville MD.
5. Keck, Jr. P.E., McElroy, S.L., 1996. Olanzapine: a novel antipsychotic medication. Today's Ther. Trends 14, 63-78.
6. Post, R.M., 1997. Initial treatment studies from the Stanley Foundation Bipolar Treatment Outcome Network. Presented at the Second International Conference on Bipolar Disorder, Pittsburgh, PA, June 19-21.
7. Spearing, M.K., Post, R.M., Leverich, G.S. et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res., in press.
8. Suppes, T., Rush, A.J., Webb, A. et al., 1996. A one year randomized trial of clozapine vs. usual care in bipolar I patients. Biol. Psychiatry 39, 531.
9. Tohen, M., Sanger, T., Tollefson, G.D., McElroy, S.L., 1997. Olanzapine versus haloperidol in the treatment of schizoaffective bipolar patients. American Psychiatric Association Annual Meeting, May 17-22, New Research, NR206. American Psychiatric Association, San Diego CA, pp. 123-124.
10. Zarate, Jr. C.A., Tohen, M., Baldessarini, R.J., 1995. Clozapine in severe mood disorders. J. Clin. Psychiatry 56, 411-417.